MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism
Objective To explore the effect of miRNA-200b on sorafenib resistance in hepatocellular carcinoma cells in order to increase the efficacy of the drug in advanced liver cancer patients. Methods Sorafenib resistant hepatocellular carcinoma HepG2-SR cell line was established by gradually increasing th...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Editorial Office of Journal of Third Military Medical University
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebebf18ffa6548c1a4574feac02cd3e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|